Replies to post #140503 on Biotech Values

[DewDiligence]

…no additional relapse for the 10 patients with SVR48, thus best would be 82%, worst 73%.

Is there a typo in your post? There should be a maximum of 9 patients (not 10) who could achieve SVR48, and your 73% figure implies that the number of cures might be only 8.